CORTESI LAURA
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of Pembrolizumab+Carboplatin in Breast Related Cancer Antigens-related Metastatic Breast Cancer (PEMBRACA) (NCT03732391) | CORTESI LAURA | 2018-12-12 |
Track CORTESI LAURA automatically
Every clearance here is in the API, with alerts when new ones post.